A Systematic Review and Meta-Analysis on the Analgesic Efficacy of Diclofenac in Bunionectomy
Future Pharmacology · 19.11.2026 · 6 (4) · 64
DOI: 10.3390/futurepharmacol6040064 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Future Pharmacology, online erschienen am 19.11.2026. Verfasst von Eduardo Gómez-Sánchez und 4 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: The aim of this systematic review was to determine the analgesic efficacy of diclofenac versus placebo in bunionectomy.
Methods
Searches were conducted in PubMed, Scopus, Embase, ClinicalTrials.gov, WHO ICTRP, and Cochrane Central Register of Controlled Trials to identify relevant clinical trials (PROSPERO ID: CRD420251136784). The potential clinical trials were evaluated using the RoB-1 tool, and data on the efficacy and adverse effects of diclofenac (diclofenac potassium liquid-filled soft gelatin capsules 25 mg, diclofenac SoluMatrix 18 and 35 mg, and diclofenac sodium enteric-coated tablet 100 mg) and placebo were recorded. The data were analyzed using Review Manager and with the computing number needed to treat from GraphPad.
Results
A total of four studies comparing diclofenac with placebo for pain control following hallux valgus surgery were included. Diclofenac demonstrated better analgesic efficacy compared with placebo, as assessed by the sum of pain intensity differences (SPID8, MD = 5.45; 95% CI = 2.42 to 8.47; n = 568) and total pain relief over 8 h (TOTPAR8, MD = 3.26; 95% CI = 0.62 to 5.90; n = 568). Furthermore, diclofenac significantly reduced the proportion of patients requiring rescue analgesia (OR = 0.10; 95% CI = 0.06 to 0.17; n = 723) and improved the overall treatment assessment (OR = 3.15; 95% CI = 1.43 to 6.92; n = 888). The pooled analysis showed a significantly lower incidence of nausea in patients receiving diclofenac compared with placebo (OR = 0.68; 95% CI = 0.49–0.93; p = 0.02). No statistically significant differences were observed for dizziness, vomiting, headache, constipation, or abdominal pain. The NNT for patients requiring rescue analgesia and overall assessment of the treatments was 3.7 (95% CI = 3 to 4.7; n = 723) and 6.6 (95% CI = 5 to 12; n = 888), respectively. The primary limitation of this study includes the relatively small number of eligible clinical trials identified in different databases.
Conclusions
The results of this systematic review demonstrate that diclofenac offers clinically meaningful analgesic efficacy after bunionectomy.
Zitieren
APA
Gómez-Sánchez, E., Aragón-Martínez, O. H., Balderas-Peña, L., Sat-Muñoz, D., & Isiordia-Espinoza, M. A. (2026). A Systematic Review and Meta-Analysis on the Analgesic Efficacy of Diclofenac in Bunionectomy. Future Pharmacology, 6(4), 64. https://doi.org/10.3390/futurepharmacol6040064
Vancouver
Gómez-Sánchez E, Aragón-Martínez OH, Balderas-Peña L, Sat-Muñoz D, Isiordia-Espinoza MA. A Systematic Review and Meta-Analysis on the Analgesic Efficacy of Diclofenac in Bunionectomy. Future Pharmacology. 2026;6(4):64. doi:10.3390/futurepharmacol6040064
BibTeX
@article{GmezSnchez2026,
author = {Gómez-Sánchez, Eduardo and Aragón-Martínez, Othoniel Hugo and Balderas-Peña, Luz-Ma-Adriana and Sat-Muñoz, Daniel and Isiordia-Espinoza, Mario Alberto},
title = {A Systematic Review and Meta-Analysis on the Analgesic Efficacy of Diclofenac in Bunionectomy},
journal = {Future Pharmacology},
year = {2026},
volume = {6},
number = {4},
pages = {64},
doi = {10.3390/futurepharmacol6040064}
}
EUVIMED